Postoperative survival of EGFR-TKI-targeted therapy in non-small cell lung cancer patients with EGFR 19 or 21 mutations: a retrospective study

Postoperative survival of EGFR-TKI-targeted therapy in non-small cell lung cancer patients with EGFR 19 or 21 mutations: a retrospective study

Abstract Background The aim of this retrospective study is to identify epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer patients and to compare the long-term postoperative outcomes in different EGFR-TKI-targeted therapy effects between the different EGFR mutation group...

Full description

Bibliographic Details
Main Authors: Wenjing Yang, Yibo Gao, Xuelian Li, Jing Zhang, Tiejun Liu, Xiaoli Feng, Hao Pan, Xiaofan Yang, Shuanghua Xie, Xiaoshuang Feng, Zhangyan Lv, Yonggang Wang, Zhaoli Chen, Jie He
Format: Article
Language:English
Published: BMC 2017-11-01
Series:World Journal of Surgical Oncology
Subjects:
Non-small cell lung cancer
EGFR mutation subtypes
Targeted therapy
Postoperative survival
Online Access:http://link.springer.com/article/10.1186/s12957-017-1251-z

Internet

http://link.springer.com/article/10.1186/s12957-017-1251-z

Similar Items